| 51 |
26172561 | Comparison of several von Willebrand factor (VWF) activity assays for monitoring patients undergoing treatment with VWF/FVIII concentrates: improved performance with a new modified automated method. | 2015 Nov |
4 |
| 52 |
26206100 | Evaluation of an heterogeneous group of patients with von Willebrand disease using an assay alternative to ristocetin induced platelet agglutination. | 2015 Oct |
5 |
| 53 |
23789907 | von Willebrand factor, clotting factors, and clotting inhibitors in apheresis platelet concentrates. | 2014 Mar |
1 |
| 54 |
24296552 | Acquired von Willebrand syndrome with a type 2B phenotype: diagnostic and therapeutic dilemmas. | 2014 |
1 |
| 55 |
24658160 | A factor VIII-derived peptide enables von Willebrand factor (VWF)-binding of artificial platelet nanoconstructs without interfering with VWF-adhesion of natural platelets. | 2014 May 7 |
1 |
| 56 |
24705415 | Echicetin coated polystyrene beads: a novel tool to investigate GPIb-specific platelet activation and aggregation. | 2014 |
2 |
| 57 |
24750680 | Technological advances in diagnostic testing for von Willebrand disease: new approaches and challenges. | 2014 Jun |
7 |
| 58 |
24750681 | Evaluation of an automated method for measuring von Willebrand factor activity in clinical samples without ristocetin. | 2014 Jun |
5 |
| 59 |
24786773 | The bleeding score predicts clinical outcomes and replacement therapy in adults with von Willebrand disease. | 2014 Jun 26 |
1 |
| 60 |
24891215 | Comparison of Von Willebrand factor (VWF) activity VWF:Ac with VWF ristocetin cofactor activity VWF:RCo. | 2014 Aug |
2 |
| 61 |
24978322 | Diagnosing von Willebrand disease: a short history of laboratory milestones and innovations, plus current status, challenges, and solutions. | 2014 Jul |
1 |
| 62 |
25103956 | Performance of two new automated assays for measuring von Willebrand activity: HemosIL AcuStar and Innovance. | 2014 Oct |
1 |
| 63 |
25192242 | Performance evaluation and multicentre study of a von Willebrand factor activity assay based on GPIb binding in the absence of ristocetin. | 2014 Dec |
4 |
| 64 |
23107512 | Establishment and characterization of a new and stable collagen-binding assay for the assessment of von Willebrand factor activity. | 2013 Apr |
1 |
| 65 |
23205618 | A comparative evaluation of a new automated assay for von Willebrand factor activity. | 2013 Mar |
3 |
| 66 |
23233321 | von Willebrand factor inhibition improves endothelial function in patients with stable angina. | 2013 Jun |
1 |
| 67 |
23520336 | No increase in bleeding identified in type 1 VWD subjects with D1472H sequence variation. | 2013 May 2 |
1 |
| 68 |
23570742 | Time course of acquired von Willebrand disease associated with two types of continuous-flow left ventricular assist devices: HeartMate II and CircuLite Synergy Pocket Micro-pump. | 2013 May |
1 |
| 69 |
23730809 | Comparison of a new chemiluminescent immunoassay for von Willebrand factor activity with the ristocetin cofactor-induced platelet agglutination method. | 2013 Nov |
2 |
| 70 |
21951857 | Screening for von Willebrand disease: contribution of an automated assay for von Willebrand factor activity. | 2012 May |
2 |
| 71 |
22155434 | An unusual case of abdominal arterial thrombosis in a young woman using desmopressin. | 2012 Jan |
1 |
| 72 |
22232560 | Identification of a small molecule that modulates platelet glycoprotein Ib-von Willebrand factor interaction. | 2012 Mar 16 |
4 |
| 73 |
22268616 | Development of an ELISA method for testing VWF ristocetin cofactor activity with improved sensitivity and reliability in the diagnosis of von Willebrand disease. | 2012 May |
2 |
| 74 |
22487084 | Differential sensitivity of von Willebrand factor (VWF) 'activity' assays to large and small VWF molecular weight forms: a cross-laboratory study comparing ristocetin cofactor, collagen-binding and mAb-based assays. | 2012 Jun |
1 |
| 75 |
22517896 | O-linked glycosylation of von Willebrand factor modulates the interaction with platelet receptor glycoprotein Ib under static and shear stress conditions. | 2012 Jul 5 |
1 |
| 76 |
22740102 | The anti-von Willebrand factor aptamer ARC1779 increases von Willebrand factor levels and platelet counts in patients with type 2B von Willebrand disease. | 2012 Aug |
3 |
| 77 |
22896002 | Clinical and prognostic implications of low or high level of von Willebrand factor in patients with Waldenstrom macroglobulinemia. | 2012 Oct 18 |
1 |
| 78 |
22922961 | Simultaneous exposure of sites in von Willebrand factor for glycoprotein Ib binding and ADAMTS13 cleavage: studies with ristocetin. | 2012 Nov |
4 |
| 79 |
23043782 | Cloning of porcine platelet glycoprotein Ibα and comparison with the human homolog. | 2012 Aug |
1 |
| 80 |
20724302 | Evaluation of an automated von Willebrand factor activity assay in von Willebrand disease. | 2011 Nov-Dec |
3 |
| 81 |
21070498 | Evaluation of an automated platelet-based assay of ristocetin cofactor activity. | 2011 Mar |
2 |
| 82 |
21148813 | Gain-of-function GPIb ELISA assay for VWF activity in the Zimmerman Program for the Molecular and Clinical Biology of VWD. | 2011 Feb 10 |
1 |
| 83 |
21186048 | A rapid, automated VWF ristocetin cofactor activity assay improves reliability in the diagnosis of Von Willebrand disease. | 2011 Apr |
1 |
| 84 |
21193108 | Rethinking the diagnosis of von Willebrand disease. | 2011 Jan |
3 |
| 85 |
21643680 | von Willebrand disease: a clinical and laboratory study of sixty-five patients. | 2011 Oct |
1 |
| 86 |
21822587 | Epitope mapping of human VWF A3 recognized by monoclonal antibody SZ-123 and SZ-125 using MALDI mass spectrometry. | 2011 Sep |
2 |
| 87 |
21917758 | Shear stress-induced unfolding of VWF accelerates oxidation of key methionine residues in the A1A2A3 region. | 2011 Nov 10 |
1 |
| 88 |
22102188 | Platelet-type von Willebrand disease: a rare, often misdiagnosed and underdiagnosed bleeding disorder. | 2011 Jul |
1 |
| 89 |
22102197 | Diagnosis and management of adult patients with von Willebrand disease in South Australia. | 2011 Jul |
1 |
| 90 |
19633908 | The influence of vasovagal response on the coagulation system. | 2010 Apr |
1 |
| 91 |
19811543 | Efficacy and safety of highly purified, doubly virus-inactivated VWF/FVIII concentrates in inherited von Willebrand's disease: results of an Italian cohort study on 120 patients characterized by bleeding severity score. | 2010 Jan |
2 |
| 92 |
20179578 | Evaluation of von Willebrand factor activity in factor VIII/von Willebrand factor concentrates with the automated von Willebrand factor: activity IL test. | 2010 Apr |
2 |
| 93 |
20216992 | Role of glycoprotein Ibalpha mobility in platelet function. | 2010 May |
1 |
| 94 |
20231421 | Common VWF exon 28 polymorphisms in African Americans affecting the VWF activity assay by ristocetin cofactor. | 2010 Jul 15 |
3 |
| 95 |
20443704 | Engineering and characterization of a chimeric anti-platelet glycoprotein Ibalpha monoclonal antibody and preparation of its Fab fragment. | 2010 Apr |
1 |
| 96 |
20589372 | Ristocetin-induced self-aggregation of von Willebrand factor. | 2010 Nov |
3 |
| 97 |
20635317 | Structure and function of a recombinant von Willebrand factor drug candidate. | 2010 Jul |
1 |
| 98 |
20727070 | Improved performance characteristics of the von Willebrand factor ristocetin cofactor activity assay using a novel automated assay protocol. | 2010 Oct |
2 |
| 99 |
20738304 | The impact of bleeding history, von Willebrand factor and PFA-100(®) on the diagnosis of type 1 von Willebrand disease: results from the European study MCMDM-1VWD. | 2010 Nov |
2 |
| 100 |
20979592 | Redox control of β2-glycoprotein I-von Willebrand factor interaction by thioredoxin-1. | 2010 Aug |
1 |